Rheopheresis: A narrative review

Kosmadakis, George

doi:10.1177/03913988221086597

Cited by 3 publications

(2 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Double filtration plasmapheresis is also called “rheopheresis” since it changes blood viscosity by removing components such as fibrinogen, α2-macroglobulin, low-density lipoprotein (LDL) cholesterol, and immunoglobulins. This may be helpful in diseases associated with microcirculatory dysfunction, including dry age-related macular degeneration, diabetic foot, peripheral arterial occlusive disease, cerebrovascular stroke, and sudden sensorineural hearing loss [26]. Other indications include hypercholesterolemia, cryoglobulinemia, and Waldenstrom’s macroglobulinemia [27].…”

Section: Description Of Different Ebp Techniquesmentioning

confidence: 99%

Nomenclature of Extracorporeal Blood Purification Therapies for Acute Indications: The Nomenclature Standardization Conference

Ostermann,

Ankawi,

Cantaluppi

et al. 2023

Blood Purif

View full text Add to dashboard Cite

The development of new extracorporeal blood purification (EBP) techniques has led to increased application in clinical practice but also inconsistencies in nomenclature and misunderstanding. In November 2022, an international consensus conference was held to establish consensus on the terminology of EBP therapies. It was agreed to define EBP therapies as techniques that use an extracorporeal circuit to remove and/or modulate circulating substances to achieve physiological homeostasis, including support of the function of specific organs and/or detoxification. Specific acute EBP techniques include renal replacement therapy, isolated ultrafiltration, hemoadsorption, and plasma therapies, all of which can be applied in isolation and combination. This paper summarizes the proposed nomenclature of EBP therapies and serves as a framework for clinical practice and future research.

show abstract

Section: Description Of Different Ebp Techniquesmentioning

confidence: 99%

Nomenclature of Extracorporeal Blood Purification Therapies for Acute Indications: The Nomenclature Standardization Conference

Ostermann,

Ankawi,

Cantaluppi

et al. 2023

Blood Purif

View full text Add to dashboard Cite

show abstract

“…Odstraňovaná plazma může být nahrazena čerstvou mraženou plazmou dárce nebo koloidním roztokem s albuminem. Jde o neselektivní metodu, kdy jsou s plazmou odstraňovány látky o vysoké molekulové hmotnosti jako autoprotilátky, aloprotilátky, imunoglobuliny, komplexy antigen-protilátka, endogenní, exogenní jedy a další složky v plazmě přítomné [1]. Vývoj aferetických metod směřoval k více selektivním procedurám.…”

unclassified

Rheopheresis and its Use in the Treatment of Diseases with Impaired Microcirculation. A Review

Paříková¹

2023

CSO

View full text Add to dashboard Cite

Rheopheresis ranks among apheretic methods. It is a selective, extra-corporeal double cascade filtration treatment. First, the plasma is separated from blood elements in extra-corporeal circulation by passing through membrane filter. The plasma is then filtrated through the second filter in order to remove proteins with a high molecular mass, e.g. lipids, fibrinogen, α2-macroglobulin, von Willebrand factor, immunoglobulin IgM. The purified plasma is then returned together with the blood elements back to the patient. The aim of the procedure is to improve the microcirculation and rheological properties of the blood. Rheopheresis is well established method for the treatment of age-related macular degeneration, acute sensorineural hearing loss, calciphylaxis, systemic sclerosis or peripheral vascular disease.

show abstract

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue

Connelly‐Smith

Alquist

Aqui

et al. 2023

J of Clinical Apheresis

111

View full text Add to dashboard Cite

The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating, and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. In the Ninth Edition, the JCA Special Issue Writing Committee has incorporated systematic review and evidence-based approaches in the grading of evidence and categorization of apheresis indications to make recommendations on the use of apheresis in a wide variety of diseases and conditions. This edition has largely maintained the general layout and concept of a fact sheet introduced in the Fourth Edition (2007). Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease or medical condition. The Ninth Edition of the JCA Special Issue comprises 91 fact sheets and

show abstract

Rheopheresis: A narrative review

Cited by 3 publications

References 36 publications

Nomenclature of Extracorporeal Blood Purification Therapies for Acute Indications: The Nomenclature Standardization Conference

Nomenclature of Extracorporeal Blood Purification Therapies for Acute Indications: The Nomenclature Standardization Conference

Rheopheresis and its Use in the Treatment of Diseases with Impaired Microcirculation. A Review

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue

Contact Info

Product

Resources

About